Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Will Sequestration Stop the Dow? Johnson & Johnson (JNJ), The Walt Disney Company (DIS)

Even after the automatic budget cuts known as “sequestration” went into effect last Friday, while Congress stood impotently on the sidelines as another deadline came and went, Tuesday’s trading session saw the Dow Jones Industrial Average surge to a new all-time high. If you’re scratching your head in disbelief, you should be — and you should also be wondering why more people aren’t joining you. Unlike the fiscal cliff that passed before the turn of the calendar, the sequester seems to have been easily dismissed by both Main Street and Wall Street.

Johnson & Johnson (JNJ)

Stephen King, who serves as the chief global economist at HSBC, commented that the growth projections being used by the U.S. when considering the economic future of the country land us in a “fantasy world.” If his projections are accurate, within an alarmingly short period we will all witness horrors on the level of those depicted by the novelist of the same name. At some level, it’s easy to dismiss the current goings-on in Washington as the cheap dinner theater it is — until you remember that politicians are playing with live ammunition (literally, in the case of the $500 billion set to be cut from the Department of Defense budget over the next decade).

Congressional Budget Office projections
The data coming out of the CBO seems to paint conflicting pictures depending on who you ask. King told CNBC: “If you look at the projections from the Congressional Budget Office (CBO) they assume that growth goes back to between 4 to 5 percent in real terms between 2014 and 2018. Their numbers suggest that the U.S. will post the fastest rate of productivity growth of any decade in the last 50 or 60 years.” This comment suggests that the future predicted by the CBO is not only rosy, but inaccurate.

According to another CBO statistic, if the sequestration cuts are allowed to stand, it will likely cost 1.4 million Americans their jobs. That’s far less rosy. If you take these two pieces of information in concert, it suggests that the number of jobs that could be lost is much higher. Even at the more conservative estimate, this is not a promising view of the future, particularly when you add in the fact that the Federal Reserve continues to reiterate its intention of keeping rates artificially low so long as unemployment remains above 6.5% and inflation stays in check. At the rate the Fed is pumping money into the economy, by the time inflation shows up in its statistics, it will be very difficult to stop, particularly if unemployment is spiking, rather than subsiding.

Charging bulls
DisneyTuesday’s session not only saw the Dow hit a new all-time high, but saw several Dow components touch 52-week highs. The day after Apple Inc. (NASDAQ:AAPL) hit a new 52-week low, Johnson & Johnson (NYSE:JNJ) and The Walt Disney Company (NYSE:DIS) touched new highs. I mention each of these names as evidence of both the widespread strength of the market and the unlikely nature of the rally. Apple has faced significant concerns over its lack of a new blockbuster product in the last few years. Rumors of the iWatch continue to circulate, but no release date has been given to the public. Meanwhile, The Walt Disney Company (NYSE:DIS) hit this new peak even as it prepares to face a serious challenge to ESPN from Fox. The strength of the stock speaks to the company’s diversification.

Stocks in the health care sector, which was the strongest sector in 2012, are staying strong in 2013. As Fool Brian Orelli explained, J&J has faced negative news from the FDA recently, but the stock has remained strong all the same. While Xarelto, the subject of the letter, is but one of many drugs in the company’s product line, negative FDA news is usually very bad for a stock. The strength shown by J&J despite this setback is a testament to the market’s momentum.

What happens next?

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.